SurModics to coat two Medtronic stents:
This article was originally published in Clinica
Executive Summary
SurModics is continuing its relationship with Arterial Vascular Engineering, now taken over by Medtronic, and will coat both the Medtronic AVE GFX2 coronary stent delivery device and the soon-to-be-introduced New Beginning D114S angioplasty balloon catheter with its Dura-Trac tracking coating. The Eden Prairie, Minnesota-based SurModics' hydrophilic PhotoLink coating improves both surface lubricity and trackability.
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.